Search research articles
Contact Us
Filters
Showing results (161-170 of 378) with videos related to
Page
of 38
Sort By:
European Journal of Endocrinology
|
July 16, 2008
Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease
Ammar Wakil, Alan S Rigby, Andrew L Clark, et al.
Clinical Endocrinology
|
January 9, 2009
Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS)
Thozhukat Sathyapalan, Li Wei Cho, Eric S Kilpatrick, et al.
Clinical Endocrinology
|
April 16, 2008
A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study
Thozhukat Sathyapalan, Li Wei Cho, Eric S Kilpatrick, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 31, 2021
Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study
Alexandra E Butler, Soha R Dargham, Ahmed Abouseif, et al.
Scientific Reports
|
February 28, 2018
Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
Soha R Dargham, Abeer El Shewehy, Youssra Dakroury, et al.
Pharmacological Research
|
December 19, 2018
Protective effects of curcumin against ischemia-reperfusion injury in the liver
Kowsar Bavarsad, Maryam Matbou Riahi, Saeideh Saadat, et al.
Diabetes Care
|
March 3, 2022
Erratum. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care 2022;45:267-272
Eric S Kilpatrick, Alexandra E Butler, Linda Ostlundh, et al.
Journal of Diabetes and Its Complications
|
June 26, 2017
Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials
Stephen L Atkin, Niki Katsiki, Maciej Banach, et al.
Diabetes Research and Clinical Practice
|
December 31, 2025
Acute hypoglycemia attenuates serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in type 2 diabetes
Abu Saleh Md Moin, Radwan Darwish, Thozhukat Sathyapalan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 22, 2024
GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences
Behina Forouzanmehr, Mohammad Amin Hemmati, Stephen L Atkin, et al.
Page
of 38
Search research articles
Search
Showing results (161-170 of 378) with videos related to
Sort By:
Page
of 38
European Journal of Endocrinology
|
July 16, 2008
Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease
Ammar Wakil, Alan S Rigby, Andrew L Clark, et al.
Clinical Endocrinology
|
January 9, 2009
Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS)
Thozhukat Sathyapalan, Li Wei Cho, Eric S Kilpatrick, et al.
Clinical Endocrinology
|
April 16, 2008
A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study
Thozhukat Sathyapalan, Li Wei Cho, Eric S Kilpatrick, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 31, 2021
Vitamin D deficiency effects on cardiovascular parameters in women with polycystic ovary syndrome: A retrospective, cross-sectional study
Alexandra E Butler, Soha R Dargham, Ahmed Abouseif, et al.
Scientific Reports
|
February 28, 2018
Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
Soha R Dargham, Abeer El Shewehy, Youssra Dakroury, et al.
Pharmacological Research
|
December 19, 2018
Protective effects of curcumin against ischemia-reperfusion injury in the liver
Kowsar Bavarsad, Maryam Matbou Riahi, Saeideh Saadat, et al.
Diabetes Care
|
March 3, 2022
Erratum. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care 2022;45:267-272
Eric S Kilpatrick, Alexandra E Butler, Linda Ostlundh, et al.
Journal of Diabetes and Its Complications
|
June 26, 2017
Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials
Stephen L Atkin, Niki Katsiki, Maciej Banach, et al.
Diabetes Research and Clinical Practice
|
December 31, 2025
Acute hypoglycemia attenuates serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in type 2 diabetes
Abu Saleh Md Moin, Radwan Darwish, Thozhukat Sathyapalan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 22, 2024
GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences
Behina Forouzanmehr, Mohammad Amin Hemmati, Stephen L Atkin, et al.
Page
of 38